CorEvitas Multiple Sclerosis (MS) Registry

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
CorEvitas
Study ID
NCT03291756
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for MS in a cohort of patients cared for by neurologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.

Key Dates

Start date
Aug 10, 2017
Status verified
Jan 2026
Primary completion
Dec 31, 2100
Completion
Dec 31, 2100

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Multiple Sclerosis
    Multiple Sclerosis Pts presenting to enrolling sites across the US are invited to enroll if eligible

Primary Outcome Measure

Number of patients with adverse events (AEs) or serious adverse events (SAEs). [ Time Frame: Time Frame: A minimum of 10 years from last patient enrolled ]

Locations (1)

FacilityCityStateZIPSite coordinators
CorEvitas, LLCWalthamMassachusetts02451-

Find similar trials in Waltham, MA

By condition
Multiple sclerosis
By specialty
NeurologyBrain disordersAutoimmune disease
By research site
CorEvitas, LLC· Waltham, MA

Related Studies